A phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphoma.
about
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityrBortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab.Update on treatment of follicular non-Hodgkin's lymphoma: focus on potential of bortezomibProteasome inhibition and combination therapy for non-Hodgkin's lymphoma: from bench to bedsideRadioimmunotherapy for B-cell non-hodgkin lymphomas.DNA damage emergency: cellular garbage disposal to the rescue?Current regimens and novel agents for mantle cell lymphoma.Emerging classes of armed antibody therapeutics against cancer
P2860
Q26776480-5B6757FA-DEE1-426F-833F-E1A9EADCD822Q33402885-0FBB6F94-401F-4B61-9C00-A6BCF8201E8BQ33414603-D889CB0D-2D35-4C15-8517-696A93F932E2Q35905929-CB045496-2C62-4D1B-8F33-4F3738A7DA10Q35989980-2EE9A14A-F8D5-4E9A-8E78-4643C6C9E061Q38019790-8FA51C23-6A25-481B-A653-74399C5D42ACQ38090434-43FDAC41-FC51-4E82-A0FE-616A3E72B7DAQ38224186-2CD6CD6C-1826-49F1-A696-57AFF489C89DQ57911948-0E0B8BBE-87E7-4573-A790-BB8984FECB87
P2860
A phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A phase I study evaluating ibr ...... e B-cell non-Hodgkin lymphoma.
@ast
A phase I study evaluating ibr ...... e B-cell non-Hodgkin lymphoma.
@en
type
label
A phase I study evaluating ibr ...... e B-cell non-Hodgkin lymphoma.
@ast
A phase I study evaluating ibr ...... e B-cell non-Hodgkin lymphoma.
@en
prefLabel
A phase I study evaluating ibr ...... e B-cell non-Hodgkin lymphoma.
@ast
A phase I study evaluating ibr ...... e B-cell non-Hodgkin lymphoma.
@en
P2093
P2860
P1433
P1476
A phase I study evaluating ibr ...... e B-cell non-Hodgkin lymphoma.
@en
P2093
Anastasia Ivanova
Anne W Beaven
Dominic T Moore
Judith Smith
Madlyn Ferraro
Peggy Ford
Tatyana Feldman
Thomas C Shea
P2860
P304
P356
10.3109/10428194.2011.608445
P577
2011-09-19T00:00:00Z